Back to all applications
Modality-aware biologics discovery
Peptides, Binders, and Antibodies
BioForge extends the same AI scientist loop to biologic modalities. The system reasons across epitopes, structures, sequence-function evidence, developability constraints, immunogenicity considerations, binding hypotheses, and assay strategy to help partners prioritize peptides, binders, and antibodies for experimental validation.
Connect epitope biology, structural context, sequence design, and developability.
Prioritize peptide, binder, and antibody candidates with explicit validation plans.
Bridge computational design with binding, expression, and functional assays.
Problem context
Why this problem matters
Modality fit
Peptides, binders, and antibodies each have different constraints for potency, stability, delivery, manufacturability, and assay design.
Structure and sequence
Candidate design improves when structural models, epitope evidence, sequence priors, and developability filters are reviewed together.
Experimental handoff
The useful output is not only a ranked sequence list, but a validation plan that wet-lab teams can run and improve from.